Will EU’s New Market Surveillance Project Hit As Hard As Notified Body Action?
Executive Summary
With control having been radically tightened over EU notified bodies over the last three years, it is possible manufacturers can expect an equally tough change for market surveillance now that competent authorities are putting together a major action plan for the activity.
You may also be interested in...
EU Roadmap: Catalyst For More Work, And A Long Way To Go
The EU Roadmap has been published. But it represents a dawning of a hard truth. The EU medtech sector still has a long way to go along the road to implementation before it gets the clarity it needs.
How EU's Competent Authority Group Is Flexing Its Muscles For New Roles
What do we know about the EU's Competent Authorities for Medical Devices group? It will have an important role in the implementation of the EU's new Regulations and in managing an EU market-surveillance project.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.